49 -4 (54) 2023 — Madrimova K.K. Matrizayeva G.D. — CLINICAL CRITERIA FOR EARLY DIAGNOSIS OF VARIOUS FORMS OF HYDATIDIFORM MOLE

CLINICAL CRITERIA FOR EARLY DIAGNOSIS OF VARIOUS FORMS OF HYDATIDIFORM MOLE

Madrimova K.K. Urgench branch of Tashkent Medical Academy

Matrizayeva G.D. Urgench branch of Tashkent Medical Academy

Resume

Hydatidiform mole thasrecently taken a leading placing gynecological practice. Vesicular drift refers to a group of diseases united by the concept of “trophoblastic disease” and developing from the tissues of the trophoblast. To date, there is no clear understanding of the causes of the occurrence off ormsof hydatidiform mole, which significantly complicates the solution of  a number of issues related to the diagnosis, treatment and prevention of this pathology. In this regard, it is necessary to further study various aspects of hydatidiform mole, the causes and mechanisms of the development   of the disease.

Key words: trophoblastic disease, hydatidiform mole, diagnosis, histological forms of hydatidiform mole.

First page

257

Last page

264

For citation: Madrimova K.K. Matrizayeva G.D. – CLINICAL CRITERIA FOR EARLY DIAGNOSIS OF VARIOUS FORMS OF HYDATIDIFORM MOLE //New Day in Medicine 4(54)2023 257-264 https://newdaymedicine.com/index.php/2023/04/20/s-7/

LIST OF REFERENCES:

1. Tavassoli F.A. and P. Devilee, Pathology Genetics of Tumours of the Breast & Female Genital Organs. IARC/World health organization classification of tumours Vol. 5. 2003, Lyon, France: WHO Press.
2. Anderson, M.C., et al., Endometrial hyperplasia, in Pathology of the Female Reproductive Tract, S.J. Robboy, M.C. Anderson, and P. Russel, Editors. Churchill Livingstone: Edinburgh. 2002; 305-329.
3. Longacre, T.A., R.L. Kempson, and M.R. Hendrickson, Endometrial hyperplasia, metaplasia and carcinoma, in Haines and Taylor Obstetrical and Gynaecological Pathology, H. Fox and M. Wells, Editors., Churchill Livingstone: New York. 1995; 421-510.
4. Boerrigter P.J., et al., Endometrial response in estrogen replacement therapy quarterly combined with a progestogen. Maturitas, 1996;24(1-2):63-71.
5. Robboy, S.J., et al., Robboy’s Pathology of the Female Reproductive Tract. 2 ed. 2009: Churchill Livingstone.
6. Ismail, S.M., Pathology of endometrium treated with tamoxifen. J Clin Pathol, 1994;47(9):827-33.
7. Kedar R.P., et al., Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet, 1994;343(8909):1318-21.
8. Sturgeon S.R., et al., Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors. Cancer Epidemiol Biomarkers Prev, 1998;7(3):231-5.
9. Ferenczy A. and M. Gelfand, The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. // Am J Obstet Gynecol, 1989;160(1):126-31.
10. Ferenczy A., M.M. Gelfand, and F. Tzipris, The cytodynamics of endometrial hyperplasia and carcinoma. A review. // Ann Pathol, 1983;3(3):189-201.
11. Hendrickson M., et al., Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables. // Gynecol Oncol, 1982;13(3):373-92.
12. Skov B.G., et al., Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia. // Int J Gynecol Pathol, 1997;16(1):33-7.
13. Kendall B.S., et al., Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. // Am J Surg Pathol, 1998;22(8):1012-9.
14. Mutter G.L., Diagnosis of premalignant endometrial disease. // J Clin Pathol, 2002;55(5):326-31.
15. Mutter G.L., et al., Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. // J Pathol, 2000;190(4):462-9.
16. Mutter G.L., M.L. Chaponot, and J.A. Fletcher, A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers. // Am J Pathol, 1995;146(2):501-8.
17. Shipley C.F., 3rd, C.L. Simmons, and G.H. Nelson, Comparison of transvaginal sonography with endometrial biopsy in asymptomatic postmenopausal women. // J Ultrasound Med, 1994;13(2):99-104.
18. Berman J.J., et al., Precancer: a conceptual working definition – results of a Consensus Conference. // Cancer Detect Prev, 2006;30(5):387-94.
19. Zaino R.J., Endometrial hyperplasia: is it time for a quantum leap to a new classification? // Int J Gynecol Pathol, 2000;19(4):314-21.
20. Tate J.E., et al., Monoclonal origin of vulvar intraepithelial neoplasia and some vulvar hyperplasias. // Am J Pathol, 1997;150(1):315-22.